leadf
logo-loader
viewXTEK Ltd
(
ASX:XTE
)

XTEK sets sights on commercialising proprietary products in second half of FY21

Snapshot

Going forwards, XTEK is in a strong financial position with cash of $10.1 million and a positive sales outlook driven by customer enquires of plates from the US and Europe.

XTEK Ltd -  XTEK sets sights on commercialising proprietary products in H2 FY21

Quick facts: XTEK Ltd

Follow
ASX:XTE

Price: 0.38 AUD

Market Cap: $26.99 m

XTEK Ltd (ASX:XTE) is targeting revenue growth in the second half of financial year 2021 as it shifts focus towards its proprietary products tailored for the government, law enforcement, military, space and commercial sectors. 

During the half-year ended 31 December 2020, the company focused on driving higher margins through a shift in its product mix, including XTclaveTM produced ballistic products and advanced composite solutions and XTatlasTM real-time contextual video, which provides unique solutions for western military forces and other government agencies. 

The company reported revenue for the first half of financial year 2021 was $12.4 million, and gross profit margins increased to 26% (compared to 18% in the first half of financial year 2020).

XTEK expects a higher revenue contribution in the second half, in line with the typical seasonality of the business.

HighCom acquisition

XTEK’s US ballistics business performed strongly with continued robust demand.

The company recently acquired HighCom Armor Solutions Inc (HighCom), and notably, the turnout for financial year 2020 was up 30% from calendar year 2019 to US$10 million.

The HighCom acquisition allows XTE to sell its products to the US military as an American supplier with production from its new US facility.

HighCom has also secured approval for a permanent export licence for ballistic products to Mexico City with current exports worth US$2.1 million.

In addition, the subsidiary has been awarded a five-year National Association of State Procurement Officials (NASPO) ValuePoint Body Armor and Ballistic Resistant Products contract for its range of personal protective equipment ballistic body armor platforms following a competitive request for proposal process.

This will allow for quick and easy access to HighCom’s Body Armor and Ballistic Resistant Products for public sector entities in all 50 states through the US.

Virolens distribution agreement

The company recently announced the signing of an exclusive distribution agreement with KeyOptions Pty Ltd, a master agent for Virolens, a test that screens for SARS-CoV-2 in around 30 seconds. 

Subject to regulatory and other relevant approvals, XTEK will supply Virolens products, consumables, training and maintenance to end-users, third-party service providers and others, who will carry out testing at sites. 

Virolens is designed to screen for SARS-CoV-2 in about 20-30 seconds with 98.1% sensitivity [true positive], 99.7% specificity [true negative] based on results of an internal in-vitro validation study of 184 samples. 

The test has been approved by the UK Medical and Healthcare product Regulation Agency and an application for approval has been lodged with the Therapeutic Goods Administration (TGA) in Australia. 

R&D investment continues

The company reported a first-half net loss of $3.5 million, which incorporated a substantial R&D investment in its proprietary technologies and its Adelaide Manufacturing Centre (AMC), a focus on fully integrating the US acquisition HighCom – as well as ongoing development of XTatlas and new product development including the sensor payload SARBI.

The AMC is set to ramp up production over the third and fourth quarters of financial year 2021 with production capacity designed to produce 80,000 SAPI plates or 40,000 helmets per annum.

The group plans to continue to invest heavily in the R&D of its proprietary products, which it is starting to commercialise internationally.

Strong second-half anticipated

Underlying demand for XTE’s products continues to be driven by defence spending, which has proven resilient to economic cycles despite the current COVID-19 environment. 

The company predicts a strong second half in its Australian-based activities in line with the typical seasonality of the business, enhanced by the ongoing delivery of Small Unmanned Aerial Systems (SUAS) to the Australian Defence Force, repair and maintenance revenue streams, and exports of XTclave manufactured products.

Going forwards, the company is in a strong financial position with cash of $10.1 million and a positive sales outlook, driven by customer inquiries of plates from the US and Europe.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

XTEK presents its world-class soldier solution innovations at Proactive...

XTEK Ltd (ASX:XTE) managing director Philippe Odouard spoke about the company’s world-class innovations in soldier solutions at Proactive's Technology Webinar on Tuesday, July 13.  He said the business revolved around helping the soldiers on the front-line, which include ‘Ballistic Solutions’...

on 16/7/21

4 min read